STOCK TITAN

Heritage Cannabis Announces Record Sales in Q4 and Continued Cost Management Driving the Company towards Positive Cash Flow

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary

Heritage Cannabis Holdings Corp. (OTCQX: HERTF) reports a third consecutive record gross revenue quarter, expecting a 20-25% increase in Q4 revenue compared to Q3. The company is focused on cost reduction and aims to achieve cash-flow positivity in early 2022. Heritage's sales growth has been impressive, with a compound annual growth rate (CAGR) of over 16% from February to August 2021, significantly higher than the average 3% for top Canadian Licensed Producers. CEO David Schwede emphasizes the company's commitment to advancing sales and maintaining prudent financial management.

Positive
  • Third consecutive record gross revenue quarter.
  • Projected Q4 revenue increase of 20-25% compared to Q3.
  • CAGR of 16% in sales from February to August 2021, outperforming peers.
Negative
  • None.

TORONTO--(BUSINESS WIRE)-- Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), is pleased to announce a third consecutive record gross revenue quarter. The company expects its fourth quarter revenue to increase between 20-25% above its record Q3 as a result of continued strong sales growth throughout the fourth quarter.

Along with growth in sales and revenue, Heritage has been focused on cost reduction across the Company and based on the current trajectory expects to be cash-flow positive in early calendar 2022.

Recently, Headset published data showing Heritage’s compound annual growth rate (CAGR) of sales from February 2021 to August 2021 of over 16% compared to the average CAGR of the top eight Canadian Licensed Producers of 3%. Also, over the latest 3 month period at the time (July to August), Heritage saw an increase in sales of over 19% in the period compared to a decline of 3% for the same group.

“Heritage has continued to outpace our larger peers in sales growth, and we don’t plan on slowing down”, commented David Schwede, CEO of Heritage. “The growth in sales and prudent cost management we have undertaken in the past few months are driving the Company towards positive cash flow as early as the beginning of calendar 2022. Our portfolio expansion of 34 skus in the flower and preroll categories, the largest segments of the market, will see results start to take shape in the coming quarters. Building a strong, self sufficient and sustainable business does not occur without strong business practices, and I am excited to see that we are within striking distance of accomplishing this in the cannabis sector.”

About Heritage Cannabis Holdings Corp.

Heritage is a leading cannabis company offering innovative products to both the medical and recreational legal cannabis markets in Canada and the U.S., operating under two licensed manufacturing facilities in Canada. The company has an extensive portfolio of high-quality cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, feelgood., CB4 and ArthroCBD.

ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORP.

“David Schwede”
David Schwede
CEO

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This press release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-looking information contained herein may include, but is not limited to, assumptions related to cash flow and capital resources, and expectations related to the supply and manufacturing agreements, the intended expansion of the Company, and partnerships and Joint Venture Partnerships.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements.

An investment in securities of the Company is speculative and subject to several risks including, without limitation, the risks discussed under the heading "Risks and Uncertainties" in the Company's annual management discussion and analysis for the year ended October 31, 2020 and dated February 26, 2021. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking information and forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended.

In connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by this notice.

For more information:

Kelly Castledine

Tel: 647-660-2560

kcastledine@heritagecann.com

Source: Heritage Cannabis Holdings Corp.

FAQ

What is the projected revenue increase for Heritage Cannabis in Q4 2021?

Heritage Cannabis expects a revenue increase of 20-25% in Q4 2021 compared to Q3.

How does Heritage Cannabis's sales growth compare to its peers?

Heritage Cannabis has a CAGR of 16% from February to August 2021, compared to 3% for the top eight Canadian Licensed Producers.

When does Heritage Cannabis expect to be cash-flow positive?

Heritage Cannabis aims to be cash-flow positive by early calendar 2022.

What was the sales increase reported by Heritage Cannabis for the latest three-month period?

Heritage Cannabis reported a sales increase of over 19% from July to August 2021.

HERITAGE CANNABIS HLDGS

OTC:HERTF

HERTF Rankings

HERTF Latest News

HERTF Stock Data

3.47M
868.29M
14.03%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Kelowna